SMS Pharmaceuticals Ltd
SMS Pharmaceuticals is a global player in API manufacturing industry. The company's products include Anti-Ulcer, Anti-fungal, Anti-migraine, Anti- Hypertensive,etc.
- Market Cap ₹ 1,217 Cr.
- Current Price ₹ 144
- High / Low ₹ 160 / 33.0
- Stock P/E 26.6
- Book Value ₹ 43.2
- Dividend Yield 0.17 %
- ROCE 13.0 %
- ROE 9.43 %
- Face Value ₹ 1.00
Pros
- No pros found. Suggest something.
Cons
- Company has a low return on equity of 11.39% for last 3 years.
- Dividend payout has been low at 6.22% of profits over last 3 years
- Debtor days have increased from 27.56 to 43.21 days.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2007 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|
193 | 611 | 438 | 463 | 465 | 412 | 488 | |
145 | 522 | 363 | 369 | 375 | 332 | 394 | |
Operating Profit | 47 | 89 | 75 | 93 | 90 | 80 | 94 |
OPM % | 25% | 15% | 17% | 20% | 19% | 19% | 19% |
Other Income | 5 | 4 | 1 | 2 | 3 | 5 | 6 |
Interest | 8 | 17 | 16 | 15 | 12 | 12 | 11 |
Depreciation | 5 | 19 | 19 | 20 | 19 | 22 | 23 |
Profit before tax | 40 | 56 | 42 | 60 | 62 | 51 | 65 |
Tax % | 36% | 26% | 14% | 33% | 34% | 36% | |
Net Profit | 25 | 41 | 28 | 32 | 40 | 32 | 46 |
EPS in Rs | 2.55 | 4.83 | 3.36 | 3.75 | 4.73 | 3.73 | 5.41 |
Dividend Payout % | 8% | 4% | 6% | 7% | 5% | 7% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -2% |
TTM: | 17% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 4% |
TTM: | 19% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 14% |
3 Years: | 22% |
1 Year: | 327% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 11% |
Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2007 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|
10 | 8 | 8 | 8 | 8 | 8 | 8 | |
Reserves | 182 | 285 | 246 | 276 | 313 | 340 | 358 |
Borrowings | 73 | 204 | 149 | 146 | 144 | 157 | 145 |
64 | 158 | 89 | 72 | 93 | 103 | 179 | |
Total Liabilities | 329 | 656 | 493 | 503 | 559 | 608 | 690 |
69 | 370 | 290 | 279 | 281 | 280 | 271 | |
CWIP | 15 | 13 | 8 | 8 | 18 | 42 | 99 |
Investments | 0 | 21 | 29 | 28 | 27 | 26 | 23 |
245 | 252 | 166 | 187 | 232 | 259 | 297 | |
Total Assets | 329 | 656 | 493 | 503 | 559 | 608 | 690 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2007 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|
14 | 61 | 73 | 32 | 50 | 40 | |
-32 | -97 | -39 | -17 | -35 | -43 | |
107 | 27 | -33 | -15 | -13 | -2 | |
Net Cash Flow | 89 | -9 | 1 | 0 | 2 | -5 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2007 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|
ROCE % | 13% | 18% | 17% | 13% | ||
Debtor Days | 114 | 36 | 18 | 19 | 20 | 43 |
Inventory Turnover | 3.06 | 3.12 | 2.58 | 2.00 |
Documents
Recent announcements
- Closure of Trading Window 30 Mar
- Announcement under Regulation 30 (LODR)-Newspaper Publication 12 Feb
- Outcome Of Board Meeting Held On 10Th February, 2021 10 Feb
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Feb
- Board Meeting Intimation for Notice Of Board Meeting To Be Held On 10.02.2021 3 Feb
View all
Annual reports
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse
-
Financial Year 2009
from nse